This topic contains a solution. Click here to go to the answer

Author Question: In deterrence theory, conventional social rewards are important because they: a. make crime a ... (Read 100 times)

crazycityslicker

  • Hero Member
  • *****
  • Posts: 537
In deterrence theory, conventional social rewards are important because they:
 
  a. make crime a rational choice.
  b. allow people to rationally decide that crime doesn't pay..
  c. encourage individuals to turn in deviants.
  d. eliminate criminal behaviors.

Question 2

When social structures do not provide adequate rewards for conformity, more people will choose deviance. This is part of which theory?
 
  a. reward theory
  b. differential association theory
  c. labeling theory
  d. deterrence theory



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

olivia_paige29

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

b

Answer to Question 2

d





 

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Hypertension is a silent killer because it is deadly and has no significant early symptoms. The danger from hypertension is the extra load on the heart, which can lead to hypertensive heart disease and kidney damage. This occurs without any major symptoms until the high blood pressure becomes extreme. Regular blood pressure checks are an important method of catching hypertension before it can kill you.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library